Form 4 for EQ Equillium, Inc.
Accepted 2021-10-07 00:00:00 ET · period of report 2021-10-06 · accession 0001209191-21-060004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-07 | 2021-10-06 | EQ | Connelly Stephen | CSO, Dir | M - OptEx | $4.16 | +8,092 | 995.5K | +0.8% | +$33.6K |
| DM | 2021-10-07 | 2021-10-06 | EQ | Connelly Stephen | CSO, Dir | S - Sale+OE | $7.01 | -8,092 | 993.0K | -0.8% | -$56.7K |
| DM | 2021-10-07 | 2021-10-06 | EQ | Connelly Stephen | CSO, Dir | M - OptEx | $0.00 | -8,092 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-06 | M | A | 5,625 | $4.75 | 998,625 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-06 | M | A | 2,467 | $2.80 | 995,467 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-06 | S | D | 2,467 | $7.01 | 993,000 | D | — | — | (F1) The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| 4 | Common | Common Stock | 2021-10-06 | S | D | 5,625 | $7.01 | 993,000 | D | — | — | (F1) The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the filer on March 31, 2021. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-10-06 | M | D | 2,467 | $0.00 | 0 | D | $2.80 · 2021-05-19 to 2030-05-18 | 2,467 Common Stock | (F5) This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on May 19, 2021, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-10-06 | M | D | 5,625 | $0.00 | 0 | D | $4.75 · 2020-12-10 to 2029-12-09 | 5,625 Common Stock | (F4) This option, representing a right to purchase twenty-five percent of the shares subject to the grant, became exercisable on December 10, 2020, which was the first anniversary of the date on which the option was granted, the remaining portion of this option vests in 36 equal monthly installments thereafter. |